526
Views
27
CrossRef citations to date
0
Altmetric
Review

Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 8557-8571 | Published online: 23 Nov 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Abdullah Alsrhani, Aisha Farhana, Yusuf Saleem Khan, Ghulam Md Ashraf, Moyad Shahwan & Anas Shamsi. (2023) Phytoconstituents as potential therapeutic agents against COVID-19: a computational study on inhibition of SARS-CoV-2 main protease. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-12.
Read now
Tao Yang, Si Chun Wang, Linyan Ye, Yasen Maimaitiyiming & Hua Naranmandura. (2023) Targeting viral proteins for restraining SARS-CoV-2: focusing lens on viral proteins beyond spike for discovering new drug targets. Expert Opinion on Drug Discovery 18:3, pages 247-268.
Read now

Articles from other publishers (25)

Aparna D. Palshetkar, Aarti U. Rasal, Aruna Murugan & Namita D. Desai. (2024) Natural Product-derived Phytochemicals as Potential Inhibitors of Angiotensin Converting Enzyme 2 (ACE2): Promising Drug Candidates for COVID-19. Current Drug Therapy 19:1, pages 13-19.
Crossref
Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Mashael AlFaifi, Majed Nahari, Alaa Almagthali, Abrar K. Thabit, Raghad Alhajaji, Reham Alharbi, Khawla Kahtani, Abeer A. Alenazi, Aisha Alharbi, Munirah M. Alghwainm, Sara M. Alotaibi, Yazeed S. Alghamdi, Samar Alotaibi, Shaden H. Alonazi, Jumanah M. Almutairi & Ramesh Vishwakarma. (2023) When antivirals backfire: An evaluation of favipiravir’s clinical outcomes in critically ill patients with COVID-19: A multicenter cohort study. Journal of Infection and Public Health 16:9, pages 1492-1499.
Crossref
Ghassan Mudher Hashim, Ghaidaa S. Hameed & Dalya Basil Hanna. (2023) The possible techniques that used to improve the bioavailablity, pharmacological activity, solubility and permeability of anti-viral drugs: Insight for COVID-19 antiviral drugs. Al Mustansiriyah Journal of Pharmaceutical Sciences 23:3, pages 231-249.
Crossref
Mo Yang, Feyisola P. Olatunji, Curran Rhodes, Sumirtha Balaratnam, Kara Dunne-Dombrink, Srinath Seshadri, Xiao Liang, Christopher P. Jones, Stuart F. J. Le Grice, Adrian R. Ferré-D’Amaré & John S. SchneeklothJr.Jr.. (2023) Discovery of Small Molecules Targeting the Frameshifting Element RNA in SARS-CoV-2 Viral Genome. ACS Medicinal Chemistry Letters.
Crossref
Daniel Paramythiotis, Eleni Karlafti, Kalliopi Veroplidou, Maria Fafouti, Georgia Kaiafa, Smaro Netta, Antonios Michalopoulos & Christos Savopoulos. (2023) Drug-Induced Acute Pancreatitis in Hospitalized COVID-19 Patients. Diagnostics 13:8, pages 1398.
Crossref
Dito Anurogo, Zahradiva Putu Fitria Hermawan, Nur Rahmah Awaliah & Taruna Ikrar. (2023) Terapi Sel Punca dan Tata Laksana Covid-19. MEDICINUS 36:1, pages 11-19.
Crossref
Yoshikazu Mutoh, Takumi Umemura, Takeshi Nishikawa, Kaho Kondo, Yuta Nishina, Kazuaki Soejima, Yoichiro Noguchi, Tomohiro Bando, Sho Ota, Tatsuki Shimahara, Shuko Hirota, Satoshi Hagimoto, Reoto Takei, Jun Fukihara, Hajime Sasano, Yasuhiko Yamano, Toshiki Yokoyama, Kensuke Kataoka, Toshiaki Matsuda, Tomoki Kimura, Toshihiko Ichihara & Yasuhiro Kondoh. (2023) Real-World Experience of the Comparative Effectiveness and Safety of Molnupiravir and Nirmatrelvir/Ritonavir in High-Risk Patients with COVID-19 in a Community Setting. Viruses 15:3, pages 811.
Crossref
Dhaneshree Bestinee Naidoo & Anil Amichund Chuturgoon. (2023) The Potential of Nanobodies for COVID-19 Diagnostics and Therapeutics. Molecular Diagnosis & Therapy 27:2, pages 193-226.
Crossref
Marjan Motiei, Lucian A. Lucia, Tomas Sáha & Petr Sáha. (2023) Current state-of-the-art review of nanotechnology-based therapeutics for viral pandemics: Special attention to COVID-19. Nanotechnology Reviews 12:1.
Crossref
Chengzhi Yu, Yayu Huang, Xin Ren & Leqiang Sun. (2023) Plant-derived Ren's oligopeptide has antiviral effects on influenza virus and SARS-CoV-2. Frontiers in Veterinary Science 9.
Crossref
Auliasari Meita Utami, Farida Rendrayani, Qisty Aulia Khoiry, Dita Noviyanti, Auliya A Suwantika, Maarten J Postma & Neily Zakiyah. (2023) Economic evaluation of COVID-19 vaccination: A systematic review. Journal of Global Health 13.
Crossref
Yukiko Moriiwa, Natsu Oyama, Ryo Otsuka, Kazuhiro Morioka, Atsushi Shoji & Akio Yanagida. (2023) Development of a colorimetric assay for quantification of favipiravir in human serum using ferrihydrite. Talanta 252, pages 123827.
Crossref
Abas Sezer, Mervisa Halilović-Alihodžić, Annissa Rachel Vanwieren, Adna Smajkan, Amina Karić, Husein Djedović & Jasmin Šutković. (2022) A review on drug repurposing in COVID-19: from antiviral drugs to herbal alternatives. Journal of Genetic Engineering and Biotechnology 20:1.
Crossref
Vyoma Snehal Trivedi, Albert Frank Magnusen, Reena Rani, Luca Marsili, Anne Michele Slavotinek, Daniel Ray Prows, Robert James Hopkin, Mary Ashley McKay & Manoj Kumar Pandey. (2022) Targeting the Complement–Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy. International Journal of Molecular Sciences 23:22, pages 14340.
Crossref
Yashika Sharma, Sulochana Kaushik, Sanjit Boora, Pawan Kumar, Ajit Kumar, Jaya P. Yadav & Samander Kaushik. (2022) Antiviral Potential of Medicinal Plants for the COVID-19. Anti-Infective Agents 20:4.
Crossref
Karuppusamy Arunachalam, Sreeja Puthanpura Sasidharan & Xuefei Yang. (2022) A concise review of mushrooms antiviral and immunomodulatory properties that may combat against COVID-19. Food Chemistry Advances 1, pages 100023.
Crossref
Mahsa Mohseni, Hosein Ameri & Morteza Arab-Zozani. (2022) Potential limitations in systematic review studies assessing the effect of the main intervention for treatment/therapy of COVID-19 patients: An overview. Frontiers in Medicine 9.
Crossref
Muhammad Nawaz, Muhammad Adnan Ashraf, Muhammad Asad Ali, Muhammad Zubair Shabbir, Muhammad Abu Bakr Shabbir, Imran Altaf, Sohail Raza, Saira Rafique, Sohail Hassan, Nageen Sardar, Adnan Mehmood, Muhammad Waqar Aziz, Sehar Fazal, Muhammad Tahir Khan, Hafiz Muhammad Moavia Atique, Ali Asif, Zia Ullah, Mubashir Iqbal, Talha Imtiaz, Muhammad Anwar, Nadia Mukhtar & Tahir Yaqub. (2022) Renessans Helps in Early Clearance of SARS-CoV-2: In-Vivo Activity of the Iodine Complex in Rhesus macaque. Life 12:9, pages 1424.
Crossref
Jesse W. Wotring, Sean M. McCarty, Khadija Shafiq, Charles J. Zhang, Theophilus Nguyen, Sophia R. Meyer, Reid Fursmidt, Carmen Mirabelli, Martin C. Clasby, Christiane E. Wobus, Matthew J. O’Meara & Jonathan Z. Sexton. (2022) In Vitro Evaluation and Mitigation of Niclosamide’s Liabilities as a COVID-19 Treatment. Vaccines 10:8, pages 1284.
Crossref
Andrey A. Ivashchenko, Bogdan A. Zagribelnyy, Yan A. Ivanenkov, Ilya A. Ivashchenko, Ruben N. Karapetian, Dmitry V. Kravchenko, Nikolay P. Savchuk, Elena V. Yakubova & Alexandre V. Ivachtchenko. (2022) The Efficacy of Aprotinin Combinations with Selected Antiviral Drugs in Mouse Models of Influenza Pneumonia and Coronavirus Infection Caused by SARS-CoV-2. Molecules 27:15, pages 4975.
Crossref
Yue-Zhi Lee, Hsing-Yu Hsu, Cheng-Wei Yang, Yi-Ling Lin, Sui-Yuan Chang, Ruey-Bing Yang, Jian-Jong Liang, Tai-Ling Chao, Chun-Che Liao, Han-Chieh Kao, Jang-Yang Chang, Huey-Kang Sytwu, Chiung-Tong Chen & Shiow-Ju Lee. (2022) The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b. Pharmaceutics 14:7, pages 1511.
Crossref
Lili Yu, Xiaoying Zhang, Sarah Ye, Hongkai Lian, Hui Wang & Jianping Ye. (2022) Obesity and COVID-19: Mechanistic Insights From Adipose Tissue. The Journal of Clinical Endocrinology & Metabolism 107:7, pages 1799-1811.
Crossref
Beata Franczyk, Jacek Rysz, Jarosław Miłoński, Tomasz Konecki, Magdalena Rysz-Górzyńska & Anna Gluba-Brzózka. (2022) Will the Use of Pharmacogenetics Improve Treatment Efficiency in COVID-19?. Pharmaceuticals 15:6, pages 739.
Crossref
Paul Andrei Negru, Andrei-Flavius Radu, Cosmin Mihai Vesa, Tapan Behl, Mohamed M. Abdel-Daim, Aurelia Cristina Nechifor, Laura Endres, Manuela Stoicescu, Bianca Pasca, Delia Mirela Tit & Simona Gabriela Bungau. (2022) Therapeutic dilemmas in addressing SARS-CoV-2 infection: Favipiravir versus Remdesivir. Biomedicine & Pharmacotherapy 147, pages 112700.
Crossref
Noha Samir Taibe, Maimona A. Kord, Mohamed Ahmed Badawy, Iart Luca Shytaj & Mahmoud M. Elhefnawi. (2022) Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment. Therapeutic Advances in Respiratory Disease 16, pages 175346662211327.
Crossref